Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sequencing-guided cHemotherapy Optimization Using Real-Time Evaluation in Newly Diagnosed DLBCL With Circulating Tumor DNA: SHORTEN-ctDNA

NCT06693830 is registered in ClinicalTrials.gov with Hua-Jay J Cherng, MD as lead sponsor.

NCT NCT06693830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06693830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sequencing-guided cHemotherapy Optimization Using Real-Time Evaluation in Newly Diagnosed DLBCL With Circulating Tumor DNA: SHORTEN-ctDNA
Lead sponsor
Hua-Jay J Cherng, MD
Phase
Not applicable
Overall status
Recruiting
Start date
December 11, 2024
Completion date
December 31, 2029
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b cell lymphoma, diffuse large b-cell lymphoma, not otherwise specified, high-grade b-cell lymphoma, lymphoma, lymphoma, b-cell